PCN6 - Comparative Efficacy And Safety Of Olaparib 300 Mg Tablets Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients With Platinum-Sensitive Relapsed Germline BRCA-Mutated Ovarian Cancer (PSROC)

Autor: Hettle, R, Sackeyfio, A, Gill, J, Siddiqui, K, Nussey, F, Friedlander, M
Zdroj: In Value in Health October-November 2017 20(9):A412-A412
Databáze: ScienceDirect
Externí odkaz: